MedicX Fund has revealed a 0.4 pence per share increase in EPRA NAV for the period to 31 March 2016 in the company’s half-year results.
You must be logged in to continue
Register for free to finish this article
Registration includes the following benefits:
To access this article REGISTER NOW
Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.